Navigation Links
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Date:5/21/2013

rovements were observed for lung function and other asthma control parameters, such as forced expiratory volume over one second (FEV1) (difference from baseline to week 12 between dupilumab and placebo of 0.27 L, p<0.001). 

Treatment-emergent adverse events (AEs) were reported by a similar proportion of patients in both groups (76.9% placebo; 80.8% dupilumab).  AEs were generally non-specific and of mild-to-moderate intensity.  The most common AEs for placebo and dupilumab were injection-site reaction (9.6% and 28.8%), nasopharyngitis (3.8% and 13.5%), upper respiratory tract infection (17.3% and 13.5%), headache (5.8% and 11.5%) and nausea (1.9% and 7.7%).

"Despite existing therapies, a significant number of patients with moderate-to-severe, persistent allergic asthma are not optimally controlled, which puts them at risk of poor clinical outcomes.  These patients contribute to the significant economic burden of asthma," said Sally Wenzel , M.D., Professor of Medicine and Director of the Asthma Institute at the University of Pittsburgh and lead investigator of this trial.  "These encouraging data support the potential role of IL-4/IL-13 blockade in an important subset of asthma patients and warrant continued clinical investigation."

"Through blockade of IL-4R alpha, dupilumab modulates signaling of both the IL-4 and IL-13 pathways, which have been implicated in the pathophysiology of Th2 mediated, or allergic, diseases such as asthma," said George D. Yancopoulos , M.D., Ph. D., Chief Scientific Officer of Regeneron and President of Regeneron Laboratories.  "These data, combined with our previously-reported positive proof-of-concept clinical results of dupilumab in atopic dermatitis, support the idea that blocking the IL-4/IL-13 pathway may be an effective mechanism to treat multiple allergic conditions.  We look forward to initiating P
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
2. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
3. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
4. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
5. NextBio Announces Translational Medicine Partnership with Sanofi
6. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
7. Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness
8. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
9. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014   ... that it has taken an exclusive worldwide licence to ... a Durham University spin-out company. ... pay an upfront fee, development and commercial milestone payments, ... also taken an option for additional exclusive licences to ...
(Date:7/28/2014)... 28, 2014 STAAR Surgical Company (NASDAQ: ... of implantable lenses and delivery systems for the eye ... and conference call with investors to July 31, 2014 ... Company rescheduled the release date and conference call to ... Hideo Watanabe , President of STAAR Japan, who ...
(Date:7/28/2014)... SOUTH SAN FRANCISCO, Calif. , July 28, 2014 ... ) today provided an update on the status of ... KB001-A collaboration with Sanofi Pasteur.  ... has reached an agreement with Sanofi Pasteur to regain ... the collaboration and licensing agreement entered into in 2010 ...
Breaking Medicine Technology:Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 3KaloBios Provides Update on KB001-A Partnership and Clinical Status 4KaloBios Provides Update on KB001-A Partnership and Clinical Status 5KaloBios Provides Update on KB001-A Partnership and Clinical Status 6
... national Tourette Syndrome Association, Inc., (TSA) has unveiled a ... to generate awareness and acceptance of all people living ... "We Have Tourette,s But Tourette,s Doesn,t Have Us" ... struggle everyday with the symptoms of involuntary sounds and ...
... NEW YORK, July 4, 2011 ... research report is available in its ... - Global Pipeline Analysis, Competitive Landscape ... http://www.reportlinker.com/p0567378/Gastrointestinal-Endoscopes---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...
Cached Medicine Technology:EHE International Showcases The National Tourette Syndrome Association, Inc. with Month-Long Window Display in Rockefeller Center Plaza 2Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 14Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 15
(Date:7/29/2014)... AZ (PRWEB) July 29, 2014 Nuanced ... they are now a HIPAA (Health Insurance Portability and ... standard for protecting the storage and transfer of Personal ... offered services compliant, Nuanced Media can effectively serve ... certification allows the agency to offer medical industry specific ...
(Date:7/29/2014)... July 29, 2014 Ticketability.com has reduced the ... already been selling at lower prices on the secure website. ... a further discount on tickets that are priced lower every ... of tickets available at Ticketability.com. , Theatergoers know that attending ... to find Phantom of the Opera tickets for sale that ...
(Date:7/29/2014)... All brides want their bridal dresses and bridal ... collection is sure to provide designs of wedding gowns ... stores. It has recently announced its new collection of ... new products come with big savings, up to 61% ... have been working in the garment industry for several ...
(Date:7/28/2014)... blood cell development have spread from Africa into nearly ... new study led by King,s College London. The international ... for the origin of changes in a key regulator ... haemoglobin is normally found in fetuses and infants, but ... to keep making it as adults experience milder symptoms ...
(Date:7/28/2014)... (PRWEB) July 29, 2014 NAPW ... at Kings County Hospital Center, as a 2014 Professional ... this prestigious distinction for leadership in community health. As ... country, spanning virtually every industry and profession, the National ... networking community with over 600,000 members and nearly 300 ...
Breaking Medicine News(10 mins):Health News:Nuanced Media Web Design Agency Now Hipaa Certified 2Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2Health News:LunaDress’ Summer Sale Has Arrived: All Its Gorgeous Lace Wedding Dresses are Affordable Now 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2
... Pharmaceutical Services, Inc. (NYSE: WST ) today ... business assets of Plastef Investissements SA. Under the agreement ... safety syringe, a passive safety system for use with ... at Plastef,s production facility located in Le Vaudreuil, Normandy, ...
... DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or ... it recently appointed Christopher P. Schnittker, CPA as its ... role, Mr. Schnittker will oversee the Accounting, Human Resources, ... Company,s Principal Accounting Officer for SEC reporting purposes. ...
... foods innovator, announced today that it is expanding its premium, all natural ... active consumers a unique, on-the-go snacking alternative that is both decadent and ... flavors--Chocolaty Cherry, Tropical and Fruit and Nut-- Bear Nake d (TM) ... Na tu ral Grain-ola ...
... finds wide variations in Web reports by states and municipalities ... local health departments in the United States get mixed marks ... about the swine flu outbreak, a new study shows. , ... April, 46 of 50 state health departments posted some information ...
... SAN DIEGO, July 7 US Farms, Inc. (Pink Sheets: USFM), ... it will be showcasing its business and products at the Natural ... 10-11, 2009 at the Venetian Resort Hotel. US Farms Booth number ... information, contact US Farms, Inc. Customer Service Department at 877-90-FARMS or ...
... DRRX ) today reported that King Pharmaceuticals, Inc. ... PTIE ) have announced that King met with ... to discuss the Complete Response Letter regarding the New Drug ... Pain Therapeutics, the outcome of the meeting last week provided ...
Cached Medicine News:Health News:West Acquires Drug Delivery Assets From Plastef Investissements SA 2Health News:DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller 2Health News:DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller 3Health News:DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller 4Health News:Bear Naked Introduces All Natural Granola Bars 2Health News:Mixed Marks for Swine Flu Updates 2Health News:US Farms, Inc. Showcasing Aloe Vera Product Line at Natural MarketPlace 2009 2Health News:REMOXY(R) NDA Update 2Health News:REMOXY(R) NDA Update 3Health News:REMOXY(R) NDA Update 4
Red Rubber Robinson Catheters (Latex)...
Silver Foley Catheter 3-way...
Silicone-Coated Foley Catheter 2-Way...
Silicone Foley Catheters 2-Way (Pediatric)...
Medicine Products: